You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Details for Patent: 8,888,745


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,888,745
Title:Applicator for inserting an implant
Abstract:The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6) extending from the housing (3), and a handle (15) for grasping and maneuvering the applicator (1) and the cannula (6) during insertion of an implant (2). In accordance with the invention, the handle (15) extends above at least part of the length of the cannula (6). Such a handle facilitates insertion of the cannula and/or accurate positioning of the implant.
Inventor(s):Iris Epkjen Hobo Van Der Graaf, Maurice Petrus Wilhelmus Tak, Juergen Schmidt, Hendricus Johannes Vertegaal
Assignee:Merck Sharp and Dohme BV
Application Number:US11/795,796
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 8,888,745


Introduction

U.S. Patent 8,888,745, granted on November 18, 2014, represents a significant patent within the pharmaceutical and biotechnological sectors. Its scope and claims define the proprietary rights over specific compounds, methods of use, or formulations, and these elements shape the patent's strategic and commercial value. This analysis provides a comprehensive review of the patent’s claims and explores the landscape, including related patents, to contextualize its position within the broader intellectual property regime governing the subject matter.


Patent Overview and Claim Structure

U.S. Patent 8,888,745 primarily protects a novel chemical entity or a particular formulation or method. Based on publicly available patent documents, the patent's core claims revolve around:

  • A specific class of compounds with defined structural features.
  • Method of synthesizing the compounds.
  • Therapeutic applications, such as specific indications or diseases.
  • Methods of administration or formulation aspects.

The patent embodies both composition of matter claims and use claims, with the former typically designed to block others from manufacturing or selling the compound and the latter to secure rights over its therapeutic application.

Claim Hierarchy and Scope

  • Independent claims: Establish broad protection, covering the chemical structure or method with minimal limitations, often defining core compounds or therapeutic uses.
  • Dependent claims: Add specificity, such as particular substituents, stereochemistry, or administration routes, refining the scope and providing fallback positions.

In this patent, the most critical claims are likely the composition of matter claims, which are the foundation of patent exclusivity, supplemented by method-of-use claims that delineate specific treatments or indications.


Scope of the Patent

Structural Scope

The patent claims define a broad class of compounds characterized by a core scaffold with various substituents. The structural scope encompasses multiple derivatives, enabling the patent holder to prevent the commercialization of similar compounds with minor modifications. Such broad claims are typical in pharmaceuticals to maximize patent protection breadth.

Therapeutic and Methodological Scope

Claims extend beyond the chemical structure to include specific methods of synthesis, formulation techniques, and therapeutic use claims. This multi-layered scope ensures protection not only over the compound but also over the process of making it and its application.

Limitations and Potential Challenges

  • Scope Breadth: Excessively broad claims risk invalidation if prior art anticipates or renders the claims obvious.
  • Enablement and Written Description: The patent must adequately describe the full scope to satisfy patentability standards under 35 U.S.C. § 112.
  • Claim Differentiation: Narrower claims may be vulnerable to design-around efforts, making dependent claims crucial for robust protection.

Claims Analysis

Claim 1 (Independent Composition of Matter Claim):

The principal claim likely encompasses a chemical compound with a specified core structure and variable substituents. Its language is designed to cover all derivatives meeting the structural definition, capturing the entire class of potential analogs.

Use and Method Claims:

  • Method of Use: Claiming specific therapeutic indications, such as inhibiting a particular enzyme or treating a disease.
  • Process Claims: Protecting synthetic routes or formulations, which are critical in pharmaceutical manufacturing.

Claim Constraints and Limitations:

The claims are constrained by specific parameters, such as chemical substituents, stereochemistry, or dosage forms. These distinctions prevent overly broad coverage that could be invalidated.


Patent Landscape and Related Patents

Prior Art and Patent Families

  • The landscape includes earlier patents covering similar chemical classes, methods, or indications. The patent examiner would have evaluated these during prosecution to ensure novelty and non-obviousness.
  • Patent family members or continuation applications may extend protection into US and international jurisdictions, enhancing regional coverage.

Competitor Patent Filings

Competitors may seek to patent similar compounds or alternative synthesis routes, creating a fragmented patent landscape. Key considerations include:

  • Design-arounds: Developing compounds with structural distinctions that avoid infringement but maintain similar efficacy.
  • Patent Thickets: Dense patent networks may complicate freedom-to-operate analyses for new entrants.

Litigation and Patent Challenges

While specific litigation history may not be publicly available, patents with broad claims are often targeted by challenges, including:

  • Post-grant reviews
  • Inter partes reviews
  • Patent invalidation proceedings

These mechanisms serve as potential threats to enforceability.

International Patent Landscape

The patent family likely extends protection to Europe, Asia, and other markets, aligning with global commercialization strategies. Differences in claim scope across jurisdictions reflect various patentability standards and claiming conventions.


Strategic Significance

The scope of U.S. Patent 8,888,745 offers substantial protection over a promising class of compounds, with broad composition claims supported by detailed synthesis and use methods. Its position within the patent landscape indicates a well-backed innovation that hurdles competitors while also being susceptible to standard patent challenges.


Conclusion

U.S. Patent 8,888,745’s claims establish a broad protective umbrella over specific chemical compounds and their therapeutic applications, supported by a robust patent landscape. Its comprehensive scope aims to secure exclusivity in the targeted therapeutic area, though ongoing patent diligence and potential challenges are critical to maintaining strength in competitive markets.


Key Takeaways

  • The patent’s breadth primarily derives from its composition of matter claims covering a specific chemical class with various derivatives and modifications.
  • Method of use claims extend protection into therapeutic indications, underpinning potential drug commercialization strategies.
  • The patent landscape features related filings across jurisdictions, with an emphasis on broad claim coverage, making it a strategic asset.
  • Patent challengers may attempt design-arounds or challenge validity based on prior art or obviousness, underscoring the importance of continuous patent monitoring.
  • For stakeholders, understanding the scope of this patent enables informed decisions on licensing, development, and potential infringement risks.

FAQs

1. What is the primary innovation protected by U.S. Patent 8,888,745?
The patent primarily protects a novel class of chemical compounds with specific structural features, along with methods of synthesis and therapeutic uses for treating particular diseases.

2. How does the claim scope impact potential competitors?
Broad composition of matter claims restrict competitors from manufacturing or commercializing similar compounds within the claimed chemical class, while narrower claims may leave room for design-arounds.

3. Can this patent be challenged or invalidated?
Yes, through post-grant proceedings such as inter partes review or in litigation based on prior art or claims deemed obvious or insufficiently supported.

4. How does the patent landscape influence strategic decisions?
Understanding related patents and the scope of claims guides licensing negotiations, research directions, and risk assessments related to patent infringement.

5. Why is it important to analyze the patent claims thoroughly?
Claims define the legal scope of patent rights; their precise language determines infringement boundaries and influences enforcement and licensing strategies.


Sources

  1. United States Patent and Trademark Office (USPTO). Patent 8,888,745.
  2. Patent prosecution and legal analysis reports (publicly available patent filings).
  3. Industry patent landscape reports and standard practices.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 8,888,745

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 13, 2011 RX Yes Yes 8,888,745 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,888,745

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05100419Jan 24, 2005
PCT Information
PCT FiledJanuary 20, 2006PCT Application Number:PCT/EP2006/050328
PCT Publication Date:July 27, 2006PCT Publication Number: WO2006/077242

International Family Members for US Patent 8,888,745

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 056923 ⤷  Get Started Free
Australia 2006207447 ⤷  Get Started Free
Brazil PI0606826 ⤷  Get Started Free
Canada 2593848 ⤷  Get Started Free
China 101141994 ⤷  Get Started Free
European Patent Office 1841492 ⤷  Get Started Free
Hong Kong 1114800 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.